Introduction: Neuroendocrine tumors of the lung (Lung-NETs) make up a heterogenous family of neoplasms showing neuroendocrine differentiation and encompass carcinoids and neuroendocrine carcinomas. On molecular grounds, they considered two completely distinct and separate tumor groups with no overlap of molecular alterations nor common developmental mechanisms. Areas covered: Two perspectives were evaluated based on an extensive review and rethinking of literature: (1) the current classification as an instrument to obtaining clinical and molecular insights into the context of Lung-NETs; and (2) an alternative and innovative interpretation of these tumors, proposing a tripartite separation into early aggressive primary high-grade neuroendocrine tumors (HGNET), differentiating or secondary HGNET, and indolent NET. Expert opinion: We herein provide an alternative outlook on Lung-NETs, which is a paradigm shift to current pathogenesis models and expands the understanding of these tumors.

Pelosi, G., Bianchi, F., Hofman, P., Pattini, L., Strobel, P., Calabrese, F., et al. (2019). Recent advances in the molecular landscape of lung neuroendocrine tumors. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 19(4), 281-297 [10.1080/14737159.2019.1595593].

Recent advances in the molecular landscape of lung neuroendocrine tumors

Albini, A;
2019

Abstract

Introduction: Neuroendocrine tumors of the lung (Lung-NETs) make up a heterogenous family of neoplasms showing neuroendocrine differentiation and encompass carcinoids and neuroendocrine carcinomas. On molecular grounds, they considered two completely distinct and separate tumor groups with no overlap of molecular alterations nor common developmental mechanisms. Areas covered: Two perspectives were evaluated based on an extensive review and rethinking of literature: (1) the current classification as an instrument to obtaining clinical and molecular insights into the context of Lung-NETs; and (2) an alternative and innovative interpretation of these tumors, proposing a tripartite separation into early aggressive primary high-grade neuroendocrine tumors (HGNET), differentiating or secondary HGNET, and indolent NET. Expert opinion: We herein provide an alternative outlook on Lung-NETs, which is a paradigm shift to current pathogenesis models and expands the understanding of these tumors.
Articolo in rivista - Review Essay
carcinoma; copy number variation; evolution; gene; genomic analysis; Ki-67 index; lung; mutation; Neuroendocrine; pathogenesis; tumor;
English
2019
19
4
281
297
none
Pelosi, G., Bianchi, F., Hofman, P., Pattini, L., Strobel, P., Calabrese, F., et al. (2019). Recent advances in the molecular landscape of lung neuroendocrine tumors. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 19(4), 281-297 [10.1080/14737159.2019.1595593].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/236390
Citazioni
  • Scopus 28
  • ???jsp.display-item.citation.isi??? 26
Social impact